Skip to content

Impacts of Subsidized Ridesharing on Drunk Driving, Alcohol Consumption, and Mobility

Impacts of Subsidized Ridesharing on Drunk Driving, Alcohol Consumption, and Mobility

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04949711
Enrollment
7034
Registered
2021-07-02
Start date
2022-05-01
Completion date
2025-04-04
Last updated
2026-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol Drinking, Driving Drunk

Keywords

Drunk driving, Ridesharing, Alcohol Drinking, Driving under the influence (DUI)

Brief summary

The purpose of this research study is to understand people's alcohol use in public places and their risks for harm. The overall goal of this study is to test the effects of subsidized ridesharing as an intervention to reduce self-reported alcohol-impaired driving, along with alcohol consumption and changes to mobility.

Detailed description

Motor vehicle crashes are the leading cause of death for people aged 13-25 years in the US, and approximately 31% of all fatal crashes involved some alcohol use. Several peer-reviewed studies have found that ridesharing was associated with fewer alcohol-involved crashes and DUI arrests. Theories of behavioral economics provide a clear theoretical mechanism by which ridesharing will reduce alcohol-involved motor vehicle crashes compared to other private transportation. However, while ridesharing may be an effective intervention to reduce alcohol-involved crashes, it may simultaneously increase alcohol consumption. This study will assess the impacts of subsidized ridesharing on impaired driving, alcohol consumption, and mobility. Participants will be randomized to either receive a rideshare voucher or an online shopping voucher, and effects on alcohol impaired driving and alcohol consumption will be measured. A GPS sub-group will use a custom smartphone application for GPS tracking to measure mobility.

Interventions

BEHAVIORALridesharing voucher

Ridesharing vouchers will be given for completing each of the online surveys, for a possible total of $80 if you complete all three surveys. You will be paid with electronic vouchers that will be sent to your cell phone.

BEHAVIORALonline shopping voucher

Online shopping vouchers will be given for completing each of the online surveys, for a possible total of $80 if you complete all three surveys. You will be paid with electronic vouchers that will be sent to your cell phone.

Sponsors

Columbia University
Lead SponsorOTHER
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* ≥ 21 years old * Reside in a study city * Have a driver's license * Have access to a motor vehicle * Have consumed alcohol in a bar in the last 30 days * Own a smartphone * Read English

Exclusion criteria

* Non-English speaking participants

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants Involved in Alcohol Impaired Driving IncidentsAt 1 week follow-up from baselineParticipants will provide two self-reported measures of impaired driving by indicating whether they "drove after drinking any alcohol" (driving after drinking) and "drove after drinking too much alcohol to drive safely" (driving while intoxicated) for each day during the previous 7 days. Data is recorded at baseline and at 1 week follow-up.

Secondary

MeasureTime frameDescription
Change in Number of Days in Alcohol ConsumptionBaseline, 1 week follow-upParticipants will be asked to state the number of drinks consumed on each day for the 7 previous days, and their responses will be used to calculate the frequency (defined as the number of drinking days) of drinking.
Average Number of Trips to Alcohol OutletsDay 3 to Day 17 of studyParticipants enrolled in the GPS sub-sample will be tracked and GPS records will be used to measure exposure to alcohol outlets and mobility.
Average Duration of Trips to Alcohol OutletsDay 3 to Day 17 of studyParticipants enrolled in the GPS sub-sample will be tracked and GPS records will be used measure exposure to alcohol outlets and mobility.
Change in The Drinker Inventory of Consequences ScoreBaseline, 1 week follow-upSelect questions related to The Drinker Inventory of Consequences (DrInC), a measure of alcohol-related consequences on which higher scores reflect greater alcohol consequences. (Score range: 0-8)

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORChristopher Morrison, PhD

Columbia University

Participant flow

Recruitment details

Participants were recruited via social media advertisements in eligible, randomly selected cities across the United States. While the cities were selected based on shared criteria, the study design is a two-arm, parallel-group randomized controlled trial where the individual is the unit of randomization, and it is not a cluster-randomized trial. To increase the likelihood of balance within cities, we utilized stratified randomization, using the city of residence as the stratification factor.

Pre-assignment details

Participants enrolled but lost to follow-up before the pre-intervention survey were not assigned to a study arm. 5856 out of 7034 were randomized to a study arm.

Baseline characteristics

Characteristic
Age, Continuous36 years
STANDARD_DEVIATION 14
Ethnicity
Hispanic or Latino
385 Participants
Ethnicity
Not Hispanic or Latino
2471 Participants
Ethnicity
Unknown or Not Reported
62 Participants
Race (NIH/OMB)
American Indian or Alaska Native
51 Participants
Race (NIH/OMB)
Asian
563 Participants
Race (NIH/OMB)
Black or African American
519 Participants
Race (NIH/OMB)
More than one race
131 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
18 Participants
Race (NIH/OMB)
Unknown or Not Reported
124 Participants
Race (NIH/OMB)
White
4163 Participants
Sex/Gender, Customized
Sex/Gender
Female
1982 Participants
Sex/Gender, Customized
Sex/Gender
Male
899 Participants
Sex/Gender, Customized
Sex/Gender
Other
29 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 2,9210 / 2,935
other
Total, other adverse events
0 / 2,9210 / 2,935
serious
Total, serious adverse events
0 / 2,9210 / 2,935

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 18, 2026